| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Jun 24 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,495 | 0.00 | 8,155 |
| 11 Jun 24 | YMAB Y-mAbs Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.01 | 14,545 | 174.69 k | 14,545 |
| 12 Mar 24 | YMAB Y-mAbs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,660 | 0.00 | 4,660 |
| 12 Mar 24 | YMAB Y-mAbs Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 16.09 | 27,900 | 448.91 k | 27,900 |
| 26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.24 | 40,848 | 132.35 k | 0 |
| 26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.24 | 73,731 | 238.89 k | 0 |
| 31 Jan 24 | ENZ Enzo Biochem | Common Stock | Grant | Acquire A | No | No | 0 | 79,365 | 0.00 | 312,383 |
